These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 38813057

  • 1. Diagnostic and prognostic performances of GALAD score in staging and 1-year mortality of hepatocellular carcinoma: A prospective study.
    Jitpraphawan O, Ruamtawee W, Treewatchareekorn M, Sethasine S.
    World J Gastroenterol; 2024 May 07; 30(17):2343-2353. PubMed ID: 38813057
    [Abstract] [Full Text] [Related]

  • 2. Alpha-fetoprotein, protein induced by vitamin K absence or antagonist-II, lens culinaris agglutinin-reactive fraction of alpha-fetoprotein alone and in combination for early detection of hepatocellular carcinoma from nonalcoholic fatty liver disease: A multicenter analysis.
    Guan MC, Ouyang W, Liu SY, Sun LY, Chen WY, Tong XM, Zhu H, Yang T.
    Hepatobiliary Pancreat Dis Int; 2022 Dec 07; 21(6):559-568. PubMed ID: 35643910
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic value of serum PIVKA-II levels for BCLC early hepatocellular carcinoma and correlation with HBV DNA.
    Wu J, Xiang Z, Bai L, He L, Tan L, Hu M, Ren Y.
    Cancer Biomark; 2018 Dec 07; 23(2):235-242. PubMed ID: 30103302
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP.
    Choi JY, Jung SW, Kim HY, Kim M, Kim Y, Kim DG, Oh EJ.
    World J Gastroenterol; 2013 Jan 21; 19(3):339-46. PubMed ID: 23372355
    [Abstract] [Full Text] [Related]

  • 5. Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.
    Lim TS, Kim DY, Han KH, Kim HS, Shin SH, Jung KS, Kim BK, Kim SU, Park JY, Ahn SH.
    Scand J Gastroenterol; 2016 Mar 21; 51(3):344-53. PubMed ID: 26340708
    [Abstract] [Full Text] [Related]

  • 6. Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein improves diagnostic accuracy for hepatocellular carcinoma.
    Lee HA, Lee YR, Lee YS, Jung YK, Kim JH, An H, Yim HJ, Jeen YT, Yeon JE, Byun KS, Seo YS.
    World J Gastroenterol; 2021 Jul 28; 27(28):4687-4696. PubMed ID: 34366629
    [Abstract] [Full Text] [Related]

  • 7. PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma.
    Feng H, Li B, Li Z, Wei Q, Ren L.
    BMC Cancer; 2021 Apr 13; 21(1):401. PubMed ID: 33849479
    [Abstract] [Full Text] [Related]

  • 8. Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma.
    Park SJ, Jang JY, Jeong SW, Cho YK, Lee SH, Kim SG, Cha SW, Kim YS, Cho YD, Kim HS, Kim BS, Park S, Bang HI.
    Medicine (Baltimore); 2017 Mar 13; 96(11):e5811. PubMed ID: 28296720
    [Abstract] [Full Text] [Related]

  • 9. A Novel Online Calculator Based on Serum Biomarkers to Detect Hepatocellular Carcinoma among Patients with Hepatitis B.
    Yang T, Xing H, Wang G, Wang N, Liu M, Yan C, Li H, Wei L, Li S, Fan Z, Shi M, Chen W, Cai S, Pawlik TM, Soh A, Beshiri A, Lau WY, Wu M, Zheng Y, Shen F.
    Clin Chem; 2019 Dec 13; 65(12):1543-1553. PubMed ID: 31672853
    [Abstract] [Full Text] [Related]

  • 10. GALAD demonstrates high sensitivity for HCC surveillance in a cohort of patients with cirrhosis.
    Singal AG, Tayob N, Mehta A, Marrero JA, El-Serag H, Jin Q, Saenz de Viteri C, Fobar A, Parikh ND.
    Hepatology; 2022 Mar 13; 75(3):541-549. PubMed ID: 34618932
    [Abstract] [Full Text] [Related]

  • 11. Applicability of BALAD score in prognostication of hepatitis B-related hepatocellular carcinoma.
    Chan SL, Mo F, Johnson P, Li L, Tang N, Loong H, Chan AW, Koh J, Chan AT, Yeo W.
    J Gastroenterol Hepatol; 2015 Oct 13; 30(10):1529-35. PubMed ID: 25968302
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic value of gamma-glutamyltransferase/aspartate aminotransferase ratio, protein induced by vitamin K absence or antagonist II, and alpha-fetoprotein in hepatitis B virus-related hepatocellular carcinoma.
    Wang Q, Chen Q, Zhang X, Lu XL, Du Q, Zhu T, Zhang GY, Wang DS, Fan QM.
    World J Gastroenterol; 2019 Sep 28; 25(36):5515-5529. PubMed ID: 31576097
    [Abstract] [Full Text] [Related]

  • 13. Lens culinaris agglutinin-reactive alpha-fetoprotein and protein induced by vitamin K absence II are potential indicators of a poor prognosis: a histopathological study of surgically resected hepatocellular carcinoma.
    Miyaaki H, Nakashima O, Kurogi M, Eguchi K, Kojiro M.
    J Gastroenterol; 2007 Dec 28; 42(12):962-8. PubMed ID: 18085353
    [Abstract] [Full Text] [Related]

  • 14. The Diagnostic Value of Serum PIVKA-II Alone or in Combination with AFP in Chinese Hepatocellular Carcinoma Patients.
    Xu F, Zhang L, He W, Song D, Ji X, Shao J.
    Dis Markers; 2021 Dec 28; 2021():8868370. PubMed ID: 33628341
    [Abstract] [Full Text] [Related]

  • 15. GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis.
    Best J, Bechmann LP, Sowa JP, Sydor S, Dechêne A, Pflanz K, Bedreli S, Schotten C, Geier A, Berg T, Fischer J, Vogel A, Bantel H, Weinmann A, Schattenberg JM, Huber Y, Wege H, von Felden J, Schulze K, Bettinger D, Thimme R, Sinner F, Schütte K, Weiss KH, Toyoda H, Yasuda S, Kumada T, Berhane S, Wichert M, Heider D, Gerken G, Johnson P, Canbay A.
    Clin Gastroenterol Hepatol; 2020 Mar 28; 18(3):728-735.e4. PubMed ID: 31712073
    [Abstract] [Full Text] [Related]

  • 16. The GALAD scoring algorithm based on AFP, AFP-L3, and DCP significantly improves detection of BCLC early stage hepatocellular carcinoma.
    Best J, Bilgi H, Heider D, Schotten C, Manka P, Bedreli S, Gorray M, Ertle J, van Grunsven LA, Dechêne A.
    Z Gastroenterol; 2016 Dec 28; 54(12):1296-1305. PubMed ID: 27936479
    [Abstract] [Full Text] [Related]

  • 17. Modeling the time-related fluctuations of AFP and PIVKA-II serum levels in patients with cirrhosis undergoing surveillance for hepatocellular carcinoma.
    Ricco G, Cosma C, Bedogni G, Biasiolo A, Guarino M, Pontisso P, Morisco F, Oliveri F, Cavallone D, Bonino F, Plebani M, Brunetto MR.
    Cancer Biomark; 2020 Dec 28; 29(2):189-196. PubMed ID: 32623383
    [Abstract] [Full Text] [Related]

  • 18. GALAD score as a prognostic model for recurrence of hepatocellular carcinoma after local ablation.
    Qiao W, Li J, Xiong Y, Zheng J, Jin R, Hu C.
    J Cancer Res Clin Oncol; 2024 May 07; 150(5):241. PubMed ID: 38713414
    [Abstract] [Full Text] [Related]

  • 19. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
    Kim HS, Park JW, Jang JS, Kim HJ, Shin WG, Kim KH, Lee JH, Kim HY, Jang MK.
    J Clin Gastroenterol; 2009 May 07; 43(5):482-8. PubMed ID: 19197197
    [Abstract] [Full Text] [Related]

  • 20. GALAD Score for the Diagnosis of Hepatocellular Carcinoma in Sub-Saharan Africa: A Validation Study in Ghanaian Patients.
    Nartey YA, Yang JD, Zemla TJ, Ayawin J, Asibey SO, El-Kassas M, Bampoh SA, Duah A, Agyei-Nkansah A, Awuku YA, Afihene MY, Yamada H, Yin J, Plymoth A, Roberts LR.
    Cancer Res Commun; 2024 Oct 01; 4(10):2653-2659. PubMed ID: 39324700
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.